Инфекция и иммунитет (Dec 2023)

Monitoring of coronavirus infection in the kyrgyz population

  • A. Yu. Popova,
  • Vyacheslav S. Smirnov,
  • O. T. Kasymov,
  • S. S. Egorova,
  • Z. S. Nurmatov,
  • I. V. Drozd,
  • A. M. Milichkina,
  • V Yu. Smolensky,
  • Z. N. Nuridinova,
  • V. A. Ivanov,
  • G. Z. Sattarova,
  • E. S. Ramsay,
  • B. I. Dzhangaziev,
  • E. V. Zueva,
  • U. U. Arabiy,
  • V. G. Drobyshevskaya,
  • O. B. Zhimbaeva,
  • A. P. Razumovskaya,
  • A. A. Totolian

DOI
https://doi.org/10.15789/2220-7619-MOC-17531
Journal volume & issue
Vol. 13, no. 6
pp. 1089 – 1108

Abstract

Read online

Purpose of the study: to study the dynamics of developing herd immunity against SARS-CoV-2 in the population of the Republic of Kyrgyzstan during COVID-19. Materials and methods. The work was carried out using the methodology for assessing population immunity developed by Rospotrebnadzor (Russia) as well as the Ministry of Health (Kypgyzstan) and the St. Petersburg Pasteur Institute. The selection of participants was carried out by questionnaire using a cloud (Internet server) service. To monitor population immunity, a cohort of 2421 subjects was formed, who participated in all stages of seromonitoring. Volunteers were randomized according to age groups (1–17, 18–29, 30–39, 40–49, 50–59, 60–69, 70+ years), regional and professional factors. Antibodies (Abs) against SARS-CoV-2 nucleocapsid (Nc) and the receptor binding domain (RBD) of S-glycoprotein were determined by qualitative and quantitative methods. The study was carried out in 3 stages according to a single scheme: 1st stage — 06/28–07/03/2021, 2nd — 21–25/02/2022 and 3rd — 31/10–04/11/2022. Since 2021, Kyrgyzstan has been vaccinating the population against SARS-CoV-2 mainly using inactivated whole-virion vaccines. Results. Population immunity against SARS-CoV-2 was predominantly accounted for by both Ab types (Nc+RBD+). By the 3rd stage, the percentage of such persons reached 99.2%, Nc–RBD– volunteers — up to 0.8%. At the 1st stage, middle-aged people dominated, but age differences were leveled out by the 2nd stage. The greatest impact on seroprevalence was found among medical workers, the smallest — among businessmen and industrial workers. Populational vaccination significantly impacted on the state of herd immunity that reached 25% by the 3rd stage. The refusals of the population in Kyrgyz Republic from vaccination noted at the 2nd and especially 3rd stages did not significantly affect level of herd immunity, which could probably be associated with asymptomatic cases of COVID-19, against which primary vaccination had a booster effect. Conclusion. The dynamics of population humoral immunity against SARS-CoV-2 included a number of changes in the level of circulating antibodies (Nc, RBD), caused by both primary infection and vaccination. The herd immunity formed in population of Kyrgyzstan allowed to reduce the incidence of COVID-19 to almost sporadic level.

Keywords